Escolar Documentos
Profissional Documentos
Cultura Documentos
e - ISSN - 2249-7722
Print ISSN - 2249-7730
Roorkee College of Pharmacy (RCP Universe) 09 milestone Roorkee-Dehradun Highway, Vill. Kishanpur, P.B.NO.104,
Roorkee, Distt. Haridwar Uttarakhand - 247667, India.
ABSTRACT
The present study was carried out to evaluated antidepressant activity of Tramadol and Tramadol plus
Imipramine in experimental animals by using Reserpine Induced Hypothermia Test. Standard drug used in tests was
Imipramine (10 mg/kg p.o.). It is a tricyclic antidepressant and it is a monoamine reuptake inhibitor. It inhibits the
reuptake of noradrenalin and serotonin (5-HT) by monoaminergic nerve terminals, and thus it facilitates transmission.
So, the possible mechanism of Tramadol and combination of Tramadol and Imipramine to decrease the immobility
time may be due to the inhibition of monoamine reuptake. These models suggest that Tramadol and combination of
Tramadol and Imipramine increases availability of biogenic amines Hence, Tramadol may produces antidepressant
due to inhibition of reuptake of noradrenalin and 5-HT (serotonin).
Key words: Serotonin, Dopamine transport, Biogenic amines, Reserpine Induced Hypothermia Test, Imipramine, and
Tramadol.
INTRODUCTION
The cause of depression was linked to
decreased brain levels of the neurotransmitters NE, 5HT, and DA, although the actual cause remains unknown
[1, 2]. Although the reuptake blockade of monoamines
(e.g., NE and 5-HT) occurs immediately upon
administration of an antidepressant, the clinical
antidepressant effects generally are not observed until
after 4 weeks of dosing It is apparent that no single
neurotransmitter theory of depressions adequate.[3, 5].
The 5-HT or NE link hypothesis maintains that both the
serotonergic and noradrenergic systems need to be
functional for an antidepressant effect to be exerted [6].
The 5-HTor NE link hypothesis is also consistent with
the rationale of the postsynaptic alteration theory of
depression, which emphasizes the importance of alpha
~ 18 ~
~ 19 ~
Table 1. Effect of Tramadol (p.o.) on Body Temperature in the Reserpine Induce Hypothermia Test using Swiss albino mice.
Basal temp.
Temperature after treatment (oC)
o
( C) after 18
S.
Treatment
Basal Temp.
hrs.
No.
1 hrs
2 hrs 3 hrs 4 hrs 5 hrs
6 hrs
7 hrs
of Reserpine
Treatment
37.4 37.52
37.46 37.44
37.56 37.36 37.76
Negative
20. 0.1
1
37.760.16
37.580.16
0.10### 0.09
0.04 0.09 0.07
Control
08
6
@@
@@@
@@@
@@@
@@@
@@@
Positive
Control
Standard
(IMP
10mg/kg)
TMD
(10mg/kg)
37.70.11
35.530.15
35.54
0.12
***
##
37.660.20
37.680.16
35.610.20
35.620.18
35.31
0.06*
**
##
36.23
0.12
36.66
0.09*
***
**@@@
35.89
0.08
***
35.4
10.
10***
36.37
0.18*
**@@@
###
35.560.13
TMD
(20mg/kg)
35.99
0.11
***
36.49
0.11*
**@@@
35.330.12
TMD
(40mg/kg)
36.06
0.12
***
36.79
0.12*
@@@
37.38
0.0
6
@@@
@@@
36.7
0.17*
*
36.7
3
0.11*
*
@@@
37.840.11
35.35
0.1
6***##
37.0
7
0.07
@@@
37.780.13
@@@
37.06
0.1
6
@@@
37.21
0.12
35.76
0.12*
**
###
36.12
0.19*
**
36.34
0.17*
**
###
###
37.68
006
37.67
0.14
@@@
@@@
37.71
0.15
37.48
0.18
37.83
0.16
37.97
0.15
@@@
@@@
@@@
37.61
0.09
37.80
0.08
38.08
0.07
@@@
@@@
@@@
38.07
0.12
37.99
0.16
37.99
0.14
@@@
@@@
@@@
@@@
37.4
1
0.09
37.86
0.09
@@@
@@@
IMP is Imipramine as a standard drug and TMD is Tramadol as a test drug. When compared with Negative Control group (p<
0.05 = *, p<0.01 = ** & p<0.001 = ***), When compared with Standard group (p<0.05 = #, p<0.01 = ## & p<0.001 = ###)
and When compared with Positive Control (p<0.05 = @, p<0.01 = @@ & p<0.001 =@@@). The results were analyzed for
statistical significance using one-way ANOVA followed by Bonferroni test. p<0.05 was considered a significant.
Table 2. Effect of combination of Tramadol and Imipramine (p.o.) on Body Temperature in the Reserpine
Hypothermia Test using Swiss albino mice using.
Basal temp. (oC)
Temperature after treatment (oC)
S.
Basal
after 18 hrs. of
Treatment
Temp.
No.
Reserpine
1 hrs
2 hrs 3 hrs 4 hrs
5 hrs
6 hrs
Treatment
37.42
37.46
37.44
37.52 37.56
37.36
37.760.1
0.0
Negative
37.580.16
0.10
0.09
0.16 0.04
0.09
1
6
8
Control
@@
@@@
@@@
@@@
@@@
@@@
###
Positive
Control
37.70.11
35.530.15
35.54
0.12
35.31
0.06*
***
##
**
##
~ 20 ~
35.41
0.1
0***
###
35.35
0.16
***
###
35.76
0.12*
**
###
36.12
0.19*
**
###
Induce
7 hrs
37.76
0.07
@@@
36.34
0.17*
**
###
Standard
(IMP
10mg/kg)
IMP+TMD
(5mg+5mg/k
g)
37.660.2
0
37.810.1
3
35.610.20
35.480.13
36.23
0.12
36.66
0.09*
***
**@@@
35.89
0.12
***
36.31
0.13*
@@@
37.07
0.07
@@@
36.70
0.15*
*
@@@
IMP+TMD
(5mg+10mg/
kg)
37.820.1
1
IMP+TMD
(5mg+20mg/
kg)
37.780.1
2
35.340.11
35.92
0.03
***
35.350.13
36.15
0.04
*** @@
36.46
0.12*
**@@@
36.91
0.10*
**@@@
37
0.11
@@@
37.43
0.13
@@@
37.38
0.06
37.68
006@
37.67
0.14
@@@
@@
@@@
37.71
0.15
37.05
0.13
37.43
0.14
37.68
0.12
37.96
0.12
@@@
@@@
@@@
37.81
0.15
37.91
0.15
38.06
0.14
@@@
@@@
@@@
38.12
0.13*
38.21
0.14
*@@@
@@@
@@@
37.49
0.12
@@@
37.97
0.15
38.08
0.15
@@@
#
@@@
IMP is Imipramine as a standard drug and TMD is Tramadol as a test drug. When compared with Negative Control group (p<
0.05 = *, p<0.01 = ** & p<0.001 = ***), When compared with Standard group (p<0.05 = #, p<0.01 = ## & p<0.001 = ###)
and When compared with Positive Control (p<0.05 = @, p<0.01 = @@ & p<0.001 =@@@). The results were analyzed for
statistical significance using one-way ANOVA followed by Bonferroni test. p<0.05 was considered a significant.
Figure 1. Effect of Tramadol (p.o.) on Body Temperature in the Reserpine Induce Hypothermia Test using Swiss
albino mice.
38.5
38
37.5
Basal Temp.
Temperature (oC)
37
1 hrs
36.5
2 hrs
36
3 hrs
35.5
4 hrs
5 hrs
35
6 hrs
34.5
7 hrs
34
33.5
Negative
Control
Positive
Control
Standard(IMP
T MD(10mg/kg) T MD(20mg/kg) T MD(40mg/kg)
10mg/kg)
The effect of Tramadol (10, 20, 40 mg/kg p.o.) and Imipramine 10mg/kg p.o. on the five minute intervals in Reserpine
Induced Hypothermia test. The results were analyzed for statistical significance using one-way ANOVA followed by
Bonferroni test. p<0.05 was considered a significant effect as compared to control group 1st to 7th hrs. Treatment.
~ 21 ~
Figure 2. Effect of combination of Tramadol and Imipramine (p.o.) on Body Temperature in the Reserpine Induce
Hypothermia Test using Swiss albino mice
39
38.5
38
Basal Temp.
1 hr
2 hr
3 hr
4 hr
5 hr
6 hr
7 hr
Temprature (oC)
37.5
37
36.5
36
35.5
35
34.5
34
33.5
Neg ative
Co ntro l
Po s itive Co ntro l
Stand ard
(IM P 10 mg /kg )
IM P+TM D
(5mg +5mg /kg )
IM P+TM D
(5mg +10 mg /kg )
IM P+TM D
(5mg +2 0 mg /kg )
The effect of combination of Imipramine and Tramadol (5+5, 5+10, 5+20 mg/kg p.o.) and Imipramine 10mg/kg p.o. in the
five minute intervals on Reserpine induced Hypothermia Test. The results were analyzed for statistical significance using
one-way ANOVA followed by Bonferroni test. p<0.05 was considered a significant effect as compared to control group 1 st to
7th hrs. Treatment.
DISCUSSION
In Reserpine Induced Hypothermia Model the
Reserpine causes depletion of biogenic amines in the
brain and which not only induces catalepsy and apoptosis
but also induces hypothermia in mice. Reserpine
decreases the body temperature. Antidepressant drugs
increases the body temperature and have slow onset of
action and action is long lasting. Tramadol and
Combination of Tramadol and Imipramine have
maintained the body temperature of mice significantly
(p<0.001) and this produces antidepressant effect as
compared to control animals. This model suggest that
Tramadol and combination of Tramadol and Imipramine
increases availability of biogenic amines Hence,
Tramadol may produces antidepressant due to inhibition
of reuptake of noradrenalin and 5-HT (serotonin).
CONCLUSION
In Present study of Evaluation of Antidepressant
Activity of Tramadol and Tramadol plus Imipramine
Using Reserpine Induced Hypothermia Model on
Experimental Animals shows that Tramadol is a potent
antidepressant. The study also revealed that combination
of Imipramine (5 mg/kg) with Tramadol (5 mg/kg, 10
mg/kg and 20 mg/kg) showed additive antidepressant
activity than the individual.
ACKNOWLEDGEMENTS
The authors would like to express their gratitude
to S. G. R. R. I. T. S. (Division of Pharmaceutical
Sciences) Dehradun for providing the animals, chemicals
and apparatus. One of the authors (Mohd .Riyaz) is also
thankful to Priya Pal for helping in research work.
REFERENCES
1. Dipiro Joseph T. Pharmacotherapy A Pathophysiological Approach. McGraw-Hill medical Publishing Division. Sixth
edition, 1235-1256.
2. Baldessarini RJ, Hardman JG, Limbrid LE. Drugs and the treatment of psychiatric disorders: Depression and anxiety
disorders. A. Goodman, New York, McGraw-Hill, 10th ed. 2000, 447484.
3. Warner V, Weissman MM, Mufson L, WickramaratnePJ. Grandparents, parents, and grandchildren at high risk for
depression: three-generation study. J Am Acad Child Adolesc Psychiatry, 38, 1999, 289296.
4. Kendler KS, Prescott CA. A population based twin study of lifetime major depression in men and women. Arch Gen
Psychiatry, 56, 1999, 3944.
~ 22 ~
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
Siever LJ, Davis KL. Overview: Toward a dysregulation hypothesis of depression. Am J Psychiatry, 142, 1985, 1017
1031.
Rothschild AJ. Management of psychotic treatment-resistant depression. Psychiatr Clin North Am., 19, 1996 237252.
Leo E, Hollister MD, Katzung BG. Basic pharmacology of Antidepressant agents: Basic and Clinical Pharmacology
Editors. Mc Graw Hill Lange publisher Editors.10 th, 2007,254.
Hopwood SE, Owesson CA, Callado LF, McLaughlin DP, Stamford JA. Effects of chronic tramadol on pre- and postsynaptic measures of monoamine function. Journal of Psychopharmacology, 15 (3), 2001, 14753.
Jubie S, Sikdar P, Antony S, Kalirajan R, Gowramma B, Gomathy S, Elango K. Synthesis And Biological Evaluation
of Some Schiff Bases of [4-(Amino) -5- Phenyl- 4h-1, 2, 4-Triazole- 3- Thiol]. Pakistan Journals of Pharmaceutical
Science, 24, 2011, 109-112.
Srinath R, Pinkal D, Saravanan J, Pravin S, Prashant R, Shenoy A. Synthesis and Evaluation of Antdepressant Activity
of Some Novel Thieno 1, 2, 3, triazine 4-ones. International Journal of Pharmaceutical Science, 1 (20), 2010, 143-150.
Pemminati S, Gopalakrishna HN, Ashok KS, Sahu SS, Meti SV Nair. Antidepressant activity of aqueous extract of fruits
of Emblica officinalis in mice. International Journal of Applied Biology and Pharmaceutical Technology, 1(2), 2010,
448-454.
Rahman H, Muralidharan P. Comparative study of antidepressant activity of methanolic extract of Nardostachys
Jatamansi DC Rhizome on normal and sleep deprived mice. Scholars Research Library, 2 (5), 2010, 441-449.
Sharma MC, Sharma S, Kohli DV. Some plant and Extracts used in Pharmacologically Activity of Anxiolytics,
Antidepressant, Analgesic, and Anti-Inflammatory Activity. Digest Journal of Nonmaterial and Biostructures, 5, 2010,
223-227.
Vogel HG, Vogel WH, Scholkens BA, Shadow J, Mullar G, Vogel WF. Drug Discovery and Evaluation of
Pharmacological Assays edition. 2, 545-585.
~ 23 ~